Naropin Injection, 2 mg/mL, APP
10 mL ampule, sterile pack (NDC 63323-0285-10)
10 mL vial, 25 count (NDC 63323-0285-13)
20 mL ampule, sterile pack (NDC 63323-0285-20)
20 mL vial, 25 count (NDC 63323-0285-23)
100 mL infusion bottle (NDC 63323-0285-65)
100 mL Novaplus infusion bottle (NDC 63323-0285-67)
200 mL infusion bottle (NDC 63323-0285-64)
Naropin Injection, 5 mg/mL, APP
20 mL ampule, sterile pack (NDC 63323-0286-20)
20 mL vial, 25 count (NDC 63323-0286-23)
30 mL sterile pack single dose vial (NDC 63323-0286-31)
30 mL vial (NDC 63323-0286-30)
100 mL infusion bottle (NDC 63323-0286-00)
200 mL infusion bottle (NDC 63323-0286-63)
30 mL Novaplus vial (NDC 63323- 0286-37)
Naropin Injection, 7.5 mg/mL, APP
20 mL ampule, sterile pack (NDC 63323-0287-20)
20 mL single-dose vial, 25 count (NDC 63323-0287-21)
Naropin Injection, 10 mg/mL, APP
10 mL ampule, sterile pack (NDC 63323-0288-10)
10 mL single dose vial, 25 count (NDC 63323-0288-11)
20 mL ampule, sterile pack (NDC 63323-0288-20)
20 mL Novaplus ampule, sterile pack (NDC 63323-0288-27)
20 mL single dose vial, 25 count (NDC 63323-0288-21)
May 15, 2013; April 1, 2013; March 20, 2013; March 5, 2013; February 7, 2013; January 22, 2013; January 14, 2013; December 19, 2012; October 22, 2012; September 26, 2012, University of Utah, Drug Information Service. Copyright 2013, Drug Information Service, University of Utah, Salt Lake City, UT.
This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.